Navigation Links
Dynatronics Announces Increases in Pre-tax Profits and Net Income for the Quarter Ended December 31, 2009
Date:1/13/2010

SALT LAKE CITY, Jan. 13 /PRNewswire-FirstCall/ -- Dynatronics Corporation (Nasdaq: DYNT) expects increases in pre-tax profits and net income for the quarter ended December 31, 2009.  Final results will be announced in the next few weeks.

Higher than expected sales in the month of December combined with reductions in expenses support the company's expectations of pre-tax profits in the range of $275,000 to $300,000 for the quarter ended December 31, 2009 compared to pre-tax profits of $89,917 for the quarter ended December 31, 2008.  Net income is expected to be approximately $170,000 to $185,000 for the quarter ended December 31, 2009 compared to net income of $54,598 for the quarter ended December 31, 2008.

"The second quarter is typically a strong sales and profit quarter for the company, but this exceeded our expectations," said Kelvyn H. Cullimore, chairman and president of Dynatronics. "Given the ongoing challenges to economic growth in the United States this increase in profitability over last year is very gratifying and indicative of improved operating efficiencies along with increased sales of high margin capital equipment."

"Looking ahead, we anticipate continued improvement in sales and net income from the expansion of our direct sales force and the preferred vendor agreements with large chains of clinics which were recently announced," added Cullimore.  "Our velocity continues to increase in a positive direction, and we expect this trend to continue."

Dynatronics manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other related medical, cosmetic and aesthetic markets. More information regarding Dynatronics is available at www.dynatronics.com.

This press release contains forward-looking statements. Those statements include references to the company's expectations and similar statements such as the statement regarding  increases in pre-tax profits and net income for the quarter ended December 31, 2009 and the expectation for continued improvement in sales and net income from the expansion of the company's direct sales force and the preferred vendor agreements with large chains of clinics.  Actual results may vary from the views expressed in the forward-looking statements contained in this release. The development and sale of the company's products are subject to a number of risks and uncertainties, including, but not limited to, changes in the regulatory environment, competitive factors, inventory risks due to shifts in market demand, market demand for the company's products, availability of financing at cost effective rates, and the risk factors listed from time to time in the company's SEC reports including, but not limited to, the report on Form 10-K for the year ended June 30, 2009.

SOURCE Dynatronics Corporation

RELATED LINKS
http://www.dynatronics.com

'/>"/>

SOURCE Dynatronics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dynatronics Inks Preferred Vendor Agreement with 1,100 Member Preferred Therapy Providers, Inc.
2. Dynatronics Receives 180-Day NASDAQ Extension
3. Dynatronics Named Sole-Source Supplier to Benchmark Physical Therapy
4. Dynatronics Announces Positive Financial Results for Quarter
5. Dynatronics to Release First Quarter Results Friday, November 13, 2009; Conference Call Set for 1:30 p.m. ET
6. Dynatronics Will Request Hearing With Nasdaq Regarding Listing Status
7. Dynatronics Appoints Douglas Sampson as Vice President of Production and Research & Development
8. The Foundry Announces Completion of Series A Financing for Twelfth Company
9. DATATRAK International, Inc. Announces Year-End Backlog
10. Stryker Corporation Announces Pricing of Senior Notes
11. Sarnova Announces Acquisition of CVC, Inc. to Expand Portfolio of Specialty Medical Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... 27, 2016 According to the ... is driving ambulatory blood pressure monitoring system market growth. ... their ability to respond to different pressure rates, leading ... lead to various cardiovascular disorders such as heart failure, ... diseases are growing in prevalence each year. WHO estimates ...
(Date:5/27/2016)... -- Amarantus BioScience Holdings, Inc. (OTCQX: ... Medicine, Neurology and Orphan Diseases, today announced that President & CEO ... investor conferences: SeeThru Equity MicroCap Conference   ... York City , NY When: Tuesday, May 31 ...   Where: Grand Hyatt Hotel, 109 East 42 nd ...
(Date:5/26/2016)... 2016 A key trend that ... emergence of new treatments. Cardax, a development stage life ... The therapy is expected to fulfil large unmet medical ... conducting studies to develop new treatments for osteoarthritis. One ... involved in osteoarthritis are being investigated, and early trials ...
Breaking Medicine Technology:
(Date:5/31/2016)... ... 2016 , ... Spartan Bioscience today introduced the Spartan Cube, ... , The Cube is exceptionally small—it takes up the space of a coffee ... any space, whether in a hospital, doctor’s office, or pharmacy. , The device’s ...
(Date:5/31/2016)... ... May 31, 2016 , ... The successful implementation of ... their laboratories as well. However, laboratories have different challenges compared to manufacturing environments. ... operations in the lab, METTLER TOLEDO has developed the Lean Lab Checklist . ...
(Date:5/31/2016)... , ... May 31, 2016 , ... The Global ... today released ten predictions on the future of wellness, travel, spa and beauty in ... travel, spa and beauty companies to leading economists and researchers - to forecast where ...
(Date:5/31/2016)... ... ... In his latest video, renowned AstroNumerologist Jesse Kalsi reveals ... candidate Donald Trump as an example, Kalsi describes the way AstroNumerology conveys the ... numbers up,” says Kalsi. “It is about looking at each individual number, since ...
(Date:5/31/2016)... ... ... The Orthopaedic Research and Education Foundation (OREF) is pleased to announce the ... his term as president in March, succeeding John J. Callaghan, MD, who remains on ... F. Kyle, MD, will serve as chair, corporate development, succeeding Thomas P. Schmalzried, MD, ...
Breaking Medicine News(10 mins):